TABLE 1

Target-to-Blood Ratios

Tracer1 h3 h4 h6 h
Sulesomab2.34 ± 0.873.44 ± 1.074.09 ± 1.314.82 ± 1.2
HSA1.57 ± 0.571.99 ± 0.642.2 ± 0.82.45 ± 0.93
P (sulesomab vs. HSA)<0.01<0.01<0.01<0.01
  • See Figure 4.